CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer

Esperanza Martin-Sanchez, Saioa Mendaza, Ane Ulazia-Garmendia, Inaki Monreal-Santesteban, Idoia Blanco-Luquin, Alicia Cordoba, Francisco Vicente-Garcia, Noemi Perez-Janices, David Escors, Diego Megias, Paula Lopez-Serra, Manel Esteller, Jose Juan Illarramendi, David Guerrero-Setas
  • Oncotarget, February 2017, Impact Journals, LLC
  • DOI: 10.18632/oncotarget.15004

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.18632/oncotarget.15004